Neurology >
Multiple Sclerosis
News, opinions and meeting coverage in neurology.
Generic Copaxone for MS Passes Clinical Test
BOSTON -- A copycat version of the multiple sclerosis drug Copaxone, known generically as glatiramer acetate, performed similarly to the original product in a head-to-head trial, paving the way for it to win regulatory approval as a generic drug.
Sep 12, 2014
Novel Drug Beats Avonex for MS Efficacy; Safety Still a Worry
BOSTON -- Daclizumab HYP cut relapse rates and disability progression in multiple sclerosis patients more effectively than interferon beta-1a (Avonex) in a phase III trial, but liver toxicity with the IL-2 inhibitor reared its head again.
Sep 12, 2014
CCSVI Practices Suboptimal but Patients Don't Mind
DALLAS -- Canadian multiple sclerosis patients who left the country to undergo the controversial procedure called chronic cerebrospinal venous insufficiency (CCSVI) often received poor pre- and postoperative care, but most were still relatively satisfied overall, a researcher reported here.
Jun 01, 2014
Gastro Effects Dog Oral MS Drug Tecfidera
DALLAS -- Large proportions of patients starting on dimethyl fumarate (Tecfidera) for multiple sclerosis need additional medications to manage the drug's GI and other side effects, and a substantial minority ultimately find the drug intolerable.
May 30, 2014
IBD Patients Prone to Other Autoimmune or Inflammatory Disorders
PHILADELPHIA-Patients with the inflammatory bowel disorders ulcerative colitis and Crohn's disease are significantly more likely to suffer from other conditions with an inflammatory or autoimmune basis, said researchers in two separate studies.
Sep 01, 2005